Jürgen Drews (medical doctor)

from Wikipedia, the free encyclopedia

Jürgen Drews (* 1933 in Berlin ) is a specialist in internal medicine and a molecular biologist .

life and work

Drews grew up in Berlin. During the Second World War he lived at times near Hirschberg in the Giant Mountains . Drews was an exchange student at Princeton . After graduating from high school in 1952, he first studied economics in Berlin. After he realized that studying economics was not for him, he switched to studying medicine , which he also completed in Berlin and Innsbruck . In 1959 he passed his state examination , after which he was employed as an assistant doctor at clinics in Berlin. He also received his doctorate in medicine in 1959. After working in the medical research center of Yale University in the USA , he completed his habilitation in 1968 in Heidelberg .

From 1970 Drews was scientific director at the Sandoz Research Institute in Vienna , where he was appointed adjunct professor in 1973. From 1985 he was head of pharmaceutical research and from 1986 head of all (global) research at Hoffmann-La Roche AG. During this time, Hoffmann La Roche acquired the American biotech company Genentech. Drews became a member of the Genentech Board of Directors. Within the pharmaceutical and biotech industries, but also beyond, Drews became known for his strategic analysis of these industries. In a large number of publications he called for a stronger research orientation in the pharmaceutical industry, which in his opinion was not being innovative enough. Drews was also able to demonstrate quantitatively what he called the innovation deficit. After leaving Roche (1998), he became a member of the supervisory boards of several other biotechnology companies in Switzerland , Germany and the USA . He was also a co-founder of Biomedicine Management Partners, GmbH based in Basel.

From 2001 to 2004 he was a manager of a fund for biotech companies at Bear Stearns Health Innoventures, LLC. (USA) . He was on the board of directors at Morphosys , Aggenix AG, and Human Genome Science, Inc.

His books The Playful Future (Birkhäuser) and In Quest of Tomorrow's Medicines (Springer, New York) were widely distributed. In addition to his work as a non-fiction author, Jürgen Drews also wrote fictional books: poems, short stories and the utopian novel El Mundo or the denial of transience Verlag Books on Demand GmbH and the novella Human Remembrance , also at BoD.

Jürgen Drews has published more than 300 scientific, science and economic policy publications in international specialist journals and in prominent weekly and daily newspapers.

Web links

Individual evidence

  1. a b c Researcher and writer Prof. Jürgen Drews. (mp3 48.6 MB) In: WDR5 table talk. January 2, 2019, accessed January 16, 2019 .
  2. ^ Supervisory Board of MorphoSys AG. (pdf 128 kb) MorphoSys AG, accessed on January 16, 2019 .